These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2572120)

  • 1. The use of a corticosteroid cream for immediate reduction in the clinical signs of acne vulgaris.
    Hull SM; Cunliffe WJ
    Acta Derm Venereol; 1989; 69(5):452-3. PubMed ID: 2572120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical trial of clobetasol propionate in Filipino vitiligo patients.
    Geraldez CB; Gutierrez GT
    Clin Ther; 1987; 9(5):474-82. PubMed ID: 3311364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind comparison between a new trihalogenated dermatocorticosteroid (halometasone) cream and clobetasol 17-propionate (Dermovate) cream.
    Schwarz KJ; Konzelmann M; Yawalkar SJ; Schoenenberger PM
    Br J Clin Pract; 1982 May; 36(5):192-6. PubMed ID: 6756453
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.
    Shalita AR; Berson DS; Thiboutot DM; Leyden JJ; Parizadeh D; Sefton J; Walker PS; Gibson JR;
    Clin Ther; 2004 Nov; 26(11):1865-73. PubMed ID: 15639698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne.
    Gollnick HP; Graupe K; Zaumseil RP
    Eur J Dermatol; 2001; 11(6):538-44. PubMed ID: 11701404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clobetasol propionate 0.05% lotion in the treatment of moderate to severe atopic dermatitis: a randomized evaluation versus clobetasol propionate emollient cream.
    Breneman D; Fleischer AB; Kaplan D; Lebwohl M; Miller B; Pariser D; Rist T; Swinyer L; Liu Y; Foley V
    J Drugs Dermatol; 2005; 4(3):330-6. PubMed ID: 15898289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clobetasol propionate 0.05% in a novel foam formulation is safe and effective in the short-term treatment of patients with delayed pressure urticaria: a randomized, double-blind, placebo-controlled trial.
    Vena GA; Cassano N; D'Argento V; Milani M
    Br J Dermatol; 2006 Feb; 154(2):353-6. PubMed ID: 16433809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent treatment of psoriasis with clobetasol propionate.
    Hradil E; Lindström C; Möller H
    Acta Derm Venereol; 1978; 58(4):375-7. PubMed ID: 82342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of actinic prurigo with intermittent short-course topical 0.05% clobetasol 17-propionate. A preliminary report.
    Lane PR; Moreland AA; Hogan DJ
    Arch Dermatol; 1990 Sep; 126(9):1211-3. PubMed ID: 2396838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of '0.05% Clobetasol + 2.5% zinc sulphate' cream vs. '0.05% Clobetasol alone' cream in the treatment of the chronic hand eczema: a double-blind study.
    Faghihi G; Iraji F; Shahingohar A; Saidat A
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):531-6. PubMed ID: 18284511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clobetasol propionate lotion, an efficient and safe alternative to clobetasol propionate emollient cream in subjects with moderate to severe plaque-type psoriasis.
    Lowe N; Feldman SR; Sherer D; Weiss J; Shavin JS; Lin YL; Foley V; Soto P
    J Dermatolog Treat; 2005 Aug; 16(3):158-64. PubMed ID: 16096182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potency ranking of two new topical corticosteroid creams containing 0.1% desonide or 0.05% halometasone utilising the human skin blanching assay.
    Meyer E; Smith EW; Haigh JM; Kanfer I
    Arzneimittelforschung; 1988 Dec; 38(12):1840-3. PubMed ID: 3245859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
    Berger R; Rizer R; Barba A; Wilson D; Stewart D; Grossman R; Nighland M; Weiss J
    Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Emovate in pediatric practice. A Swiss study on a new local corticosteroid].
    Graber W; Miescher A; Schneider HJ
    Ther Umsch; 1983 May; 40(5):449-53. PubMed ID: 6346567
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
    Menter A; Abramovits W; Colón LE; Johnson LA; Gottschalk RW
    J Drugs Dermatol; 2009 Jan; 8(1):52-7. PubMed ID: 19180896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple granulation tissue lesions occurring in isotretinoin treatment of acne vulgaris--successful response to topical corticosteroid therapy.
    Miller RA; Ross JB; Martin J
    J Am Acad Dermatol; 1985 May; 12(5 Pt 1):888-9. PubMed ID: 3159762
    [No Abstract]   [Full Text] [Related]  

  • 17. Topical tetracycline in the treatment of acne vulgaris.
    Adişen E; Kaymak Y; Gurer MA; Durukan E
    J Drugs Dermatol; 2008 Oct; 7(10):953-5. PubMed ID: 19112759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical taurine bromamine, a new candidate in the treatment of moderate inflammatory acne vulgaris: a pilot study.
    Marcinkiewicz J; Wojas-Pelc A; Walczewska M; Lipko-Godlewska S; Jachowicz R; Maciejewska A; Białecka A; Kasprowicz A
    Eur J Dermatol; 2008; 18(4):433-9. PubMed ID: 18573718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris.
    Tanghetti E; Dhawan S; Torok H; Kircik L
    Dermatol Online J; 2007 Jul; 13(3):1. PubMed ID: 18328195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic study of a concentrated cream of clobetasol propionate (0.5% in dermatology)].
    Desmons F; Desurmont B
    Lille Med; 1980 Nov; 25(9):538-40. PubMed ID: 7453493
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.